The device center released its guidance priorities for fiscal year 2014; among them are final guidances on the 510(k) program and in vitro companion diagnostics, as well as a draft guidance on benefit-risk determinations in 510(k)s.
As part of the 2012 medical device user fee agreement, FDA was required to keep an updated website